菌酸和阿扎西奥普林在间歇性肺病中的疗效:系统性审查和元分析
Francesco Lombardi1, Iain Stewart2, Laura Fabbri2
1Pulmonary Medicine, Policlinico Universitario Agostino Gemelli, Roma, Italy lombardi.f89@gmail.com.
BMJ open respiratory research
|February 27, 2024
概括
菌酸莫菲蒂尔 (MMF) 和阿扎西奥普林 (AZA) 在间歇性肺病 (ILD) 中改善肺功能的证据确定性非常低. 需要进一步的高质量的RCT来确认MMF.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 间歇性肺病 (ILD) 涵盖了一系列影响肺组织的疾病,通常需要免疫调节治疗.
- 菌酸莫菲蒂尔 (MMF) 和阿扎西奥普林 (AZA) 是常用于管理ILD的药物,但它们在保持肺功能方面的有效性需要进行严格的评估.
研究的目的:
- 系统地审查和评估MMF或AZA在ILD患者的肺功能上的疗效.
- 为了比较MMF和AZA与安慰剂和治疗组内的影响.
主要方法:
- 随机对照试验 (RCT) 和前性观察性研究的系统审查和元分析.
- 包括的研究集中在接受MMF或AZA治疗的ILD患者身上,测量预测的强迫生命能力 (%FVC) 和预测的第一氧化碳扩散肺容量 (%DLco) 的变化.
- 排除标准包括回顾性研究和高剂量同时服用类固醇的研究.
主要成果:
- 在定量综合中包括了12项研究.
- 与安慰剂相比,三个MMFRCT对初级终点 (%FVC,%DLco) 没有显著影响.
- 货币市场基金在子组分析中显示FVC (2,03%) 和DLco (4,42%) 的总体增长很小,但所有证据的确定性都非常低.
结论:
- 目前关于MMF和AZA对ILD的有限RCT的证据确定性非常低.
- 虽然货币货币基金可能在保护肺功能方面提供一些好处,但对这种效应的信心较低,需要进一步调查.
- 高确定性证据需要精心设计的RCT,专门评估MMF在ILD群体中的疗效.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
246
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
246
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
01:19Antiasthma Drugs: Leukotriene Modifiers
298
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
298
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
118
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
118
01:29Drugs for Treatment of Ulcerative Colitis in IBD
141
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141